Haznedaroglu, I. (2013) “MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)”, Mediterranean Journal of Hematology and Infectious Diseases, 6(1), p. e2014009. doi: 10.4084/mjhid.2014.009.